150 related articles for article (PubMed ID: 2022878)
21. Topical immunotherapy in dermatology.
Buckley DA; du Vivier AW
Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
[TBL] [Abstract][Full Text] [Related]
22. [Alopecia areata. Only an inflammation can still help].
Paukstadt W
MMW Fortschr Med; 2001 Sep; 143(39):8-10. PubMed ID: 11680931
[No Abstract] [Full Text] [Related]
23. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
van der Steen PH; Boezeman JB; Happle R
Dermatology; 1992; 184(3):198-201. PubMed ID: 1392112
[TBL] [Abstract][Full Text] [Related]
24. Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
Avitabile S; Sordi D; Garcovich S; Colonna L; De Luca A; Nasorri F; Mazzanti C; Cavani A
J Dermatol; 2015 Jan; 42(1):98-9. PubMed ID: 25495487
[No Abstract] [Full Text] [Related]
25. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
[TBL] [Abstract][Full Text] [Related]
26. [Immunologic stimulation in the therapy of alopecia areata].
Bokonjić M; Karacić I; Milicević M
Med Arh; 1986; 40(6):309-11. PubMed ID: 3272335
[No Abstract] [Full Text] [Related]
27. Diphenylcyclopropenone immunotherapy in ophiasis.
Singh G; Okade R; Naik C; Dayanand CD
Indian J Dermatol Venereol Leprol; 2007; 73(6):432-3. PubMed ID: 18032873
[No Abstract] [Full Text] [Related]
28. An update on alopecia areata.
Kos L; Conlon J
Curr Opin Pediatr; 2009 Aug; 21(4):475-80. PubMed ID: 19502982
[TBL] [Abstract][Full Text] [Related]
29. Contact urticaria during topical immunotherapy.
Tosti A; Guerra L; Bardazzi F
Contact Dermatitis; 1989 Sep; 21(3):196-7. PubMed ID: 2791547
[No Abstract] [Full Text] [Related]
30. Management of alopecia areata.
Harries MJ; Sun J; Paus R; King LE
BMJ; 2010 Jul; 341():c3671. PubMed ID: 20656774
[No Abstract] [Full Text] [Related]
31. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
32. Modified immunotherapy for alopecia areata.
Yoshimasu T; Furukawa F
Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
[TBL] [Abstract][Full Text] [Related]
33. Home-based contact immunotherapy with diphenylcyclopropenone improves compliance with the recommended follow-up for patients with alopecia areata: A retrospective cohort study.
Kim BJ; Lee S; Lee CH; Lee WS
J Am Acad Dermatol; 2020 May; 82(5):1223-1225. PubMed ID: 31678469
[No Abstract] [Full Text] [Related]
34. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
35. Alopecia areata: autoimmunity--the evidence is compelling.
Kalish RS; Gilhar A
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis and therapy of alopecia areata].
Happle R
Z Hautkr; 1990 Dec; 65(12):1096-100. PubMed ID: 2087837
[TBL] [Abstract][Full Text] [Related]
37. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
[TBL] [Abstract][Full Text] [Related]
38. [Immunostimulation therapy in patients with alopecia areata].
Jautová J; Jarcusková D; Dubivská M; Ficová M
Bratisl Lek Listy; 1995 Mar; 96(3):160-4. PubMed ID: 7633931
[TBL] [Abstract][Full Text] [Related]
39. Blockage of T Cell Activation via Anti-CD40 and Anti-CD154 Monoclonal Antibodies can Possibility Treat Alopecia Areata.
Tavakolpour S; Daneshpazhooh M; Mahmoudi HR
Scand J Immunol; 2016 Jun; 83(6):463-4. PubMed ID: 26972309
[No Abstract] [Full Text] [Related]
40. Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata.
Firooz A; Bouzari N; Mojtahed F; Pazoki-Toroudi H; Nassiri-Kashani M; Davoudi M; Dowlati Y
J Eur Acad Dermatol Venereol; 2005 May; 19(3):393-4. PubMed ID: 15857483
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
